Clinical Trial Update: A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis [Phase 2]

View source ↗

Summary

A Phase 2 feasibility trial evaluating STIMULAN VG in diabetic foot osteomyelitis, comparing safety and between-group effect sizes against standard of care; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Osteomyelitis

Drugs mentioned

• Stimulan VG (calcium sulfate bone graft substitute)

Snippet

Sponsor: Biocomposites Ltd | Conditions: Diabetic Foot Osteomyelitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING